Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (13758)	3/1/2021 10:29:16 AM
From: Moonray	6 Recommendations Recommended By Cogito Ergo Sum Glenn Petersen kidl oldbeachlvr Sam and 1 more member Read Replies (1) \| Respond to of 22882

J&J CEO: Our science is well positioned to deal with variants “The great news is the agility, the flexibility that we have to actually literally be designing software real time to help address of some of these new and emerging variants,” Johnson & Johnson CEO Alex Gorsky told CNBC’s “Squawk Box” on Monday. “We’re quite confident based upon the clinical data that we already have with our vaccine that we’re going to see a very robust response,” he said. A lot more in video at: cnbc.com Wow! J&J may have eliminated future pandemics emanating from strains of COVID-19. o~~~ O